Literature DB >> 22048994

Clinical and electrophysiological characteristics in patients with sustained monomorphic reentrant ventricular tachycardia associated with dilated-phase hypertrophic cardiomyopathy.

Akiko Ueda1, Seiji Fukamizu, Kyoko Soejima, Tamotsu Tejima, Mitsuhiro Nishizaki, Takashi Nitta, Youichi Kobayashi, Masayasu Hiraoka, Harumizu Sakurada.   

Abstract

AIMS: Little is known about sustained monomorphic ventricular tachycardia (SMVT) associated with dilated-phase hypertrophic cardiomyopathy (DHCM). The purpose of this study was to clarify the clinical characteristics and effectiveness of catheter ablation for SMVTs in DHCM patients. METHODS AND
RESULTS: Five patients with DHCM (mean age; 67.0 years old, five males) who underwent catheter ablation for drug-refractory SMVTs were included the study. Four of five patients suffered from electrical storm. When the endocardial ablation failed, epicardial and/or intracoronary ethanol ablation, or surgical cryoablation was performed. We reviewed all ablation procedures and electrocardiogram (ECG) of targeted SMVTs. A total of 13 SMVTs were targeted for ablation. Mechanism of all ventricular tachycardias (VTs) was diagnosed as reentry. Endocardial ablation successfully eliminated all VTs in two patients. The remaining three patients needed epicardial ablation, intracoronary ethanol ablation, and surgical cryoablation. All but one VT arose from the basal septum, basal anterior to anterolateral left ventricle (LV). Although the ECGs demonstrated similar features of idiopathic outflow or mitral annulus VTs reflecting the origins, there were characteristic multiple QRS deflections. Following the ablation, four (80%) of the five patients are free from VT recurrence during 18 months of the follow-up period.
CONCLUSIONS: In DHCM patients, VT circuits predominantly distributed in the basal septum and the basal anterior to anterolateral LV. In addition to the endocardial ablation, alternative approaches were required in some patients.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22048994     DOI: 10.1093/europace/eur344

Source DB:  PubMed          Journal:  Europace        ISSN: 1099-5129            Impact factor:   5.214


  6 in total

1.  2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias.

Authors:  Edmond M Cronin; Frank M Bogun; Philippe Maury; Petr Peichl; Minglong Chen; Narayanan Namboodiri; Luis Aguinaga; Luiz Roberto Leite; Sana M Al-Khatib; Elad Anter; Antonio Berruezo; David J Callans; Mina K Chung; Phillip Cuculich; Andre d'Avila; Barbara J Deal; Paolo Della Bella; Thomas Deneke; Timm-Michael Dickfeld; Claudio Hadid; Haris M Haqqani; G Neal Kay; Rakesh Latchamsetty; Francis Marchlinski; John M Miller; Akihiko Nogami; Akash R Patel; Rajeev Kumar Pathak; Luis C Saenz Morales; Pasquale Santangeli; John L Sapp; Andrea Sarkozy; Kyoko Soejima; William G Stevenson; Usha B Tedrow; Wendy S Tzou; Niraj Varma; Katja Zeppenfeld
Journal:  J Interv Card Electrophysiol       Date:  2020-10       Impact factor: 1.900

2.  2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias.

Authors:  Edmond M Cronin; Frank M Bogun; Philippe Maury; Petr Peichl; Minglong Chen; Narayanan Namboodiri; Luis Aguinaga; Luiz Roberto Leite; Sana M Al-Khatib; Elad Anter; Antonio Berruezo; David J Callans; Mina K Chung; Phillip Cuculich; Andre d'Avila; Barbara J Deal; Paolo Della Bella; Thomas Deneke; Timm-Michael Dickfeld; Claudio Hadid; Haris M Haqqani; G Neal Kay; Rakesh Latchamsetty; Francis Marchlinski; John M Miller; Akihiko Nogami; Akash R Patel; Rajeev Kumar Pathak; Luis C Sáenz Morales; Pasquale Santangeli; John L Sapp; Andrea Sarkozy; Kyoko Soejima; William G Stevenson; Usha B Tedrow; Wendy S Tzou; Niraj Varma; Katja Zeppenfeld
Journal:  Europace       Date:  2019-08-01       Impact factor: 5.214

Review 3.  Catheter ablation for premature ventricular contractions and ventricular tachycardia in patients with heart failure.

Authors:  Saurabh Kumar; William G Stevenson; Roy M John
Journal:  Curr Cardiol Rep       Date:  2014-09       Impact factor: 2.931

4.  Epicardial Ventricular Tachycardia Ablation for Which Patients?

Authors:  Laurent Roten; Frédéric Sacher; Matthew Daly; Patrizio Pascale; Yuki Komatsu; Khaled Ramoul; Daniel Scherr; Arnaud Chaumeil; Ashok Shah; Arnaud Denis; Nicolas Derval; Mélèze Hocini; Michel Haïssaguerre; Pierre Jaïs
Journal:  Arrhythm Electrophysiol Rev       Date:  2012-09

Review 5.  Patient Selection for Epicardial Ablation-Part I: The Role of Epicardial Ablation in Various Cardiac Disease States.

Authors:  Justin A Edward; Duy T Nguyen
Journal:  J Innov Card Rhythm Manag       Date:  2019-11-15

6.  Identifying the true origin of sustained monomorphic ventricular tachycardia associated with dilated-phase hypertrophic cardiomyopathy: A case of successful catheter ablation.

Authors:  Hiroshi Kawakami; Takayuki Nagai; Akira Fujii; Teruyoshi Uetani; Kazuhisa Nishimura; Katsuji Inoue; Jun Suzuki; Kazuhiro Satomi; Takafumi Okura; Jitsuo Higaki; Akiyoshi Ogimoto
Journal:  J Arrhythm       Date:  2015-07-14
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.